ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer

Céline Montavon Sartorius, Andreas Schoetzau, Henriette Kettelhack, Daniel Fink, Neville F. Hacker, André Fedier, Francis Jacob, Viola Heinzelmann-Schwarz

Open source

DOI
10.1371/journal.pone.0195213
Published
2018-03-29
Container
PLOS ONE
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0195213,
  title = {ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer},
  author = {Céline Montavon Sartorius and Andreas Schoetzau and Henriette Kettelhack and Daniel Fink and Neville F. Hacker and André Fedier and Francis Jacob and Viola Heinzelmann-Schwarz},
  year = {2018},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0195213},
  url = {https://doi.org/10.1371/journal.pone.0195213}
}

RIS

TY  - JOUR
TI  - ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer
AU  - Céline Montavon Sartorius
AU  - Andreas Schoetzau
AU  - Henriette Kettelhack
AU  - Daniel Fink
AU  - Neville F. Hacker
AU  - André Fedier
AU  - Francis Jacob
AU  - Viola Heinzelmann-Schwarz
PY  - 2018
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0195213
UR  - https://doi.org/10.1371/journal.pone.0195213
ER  - 

APA

Sartorius, C. M., Schoetzau, A., Kettelhack, H., Fink, D., Hacker, N. F., Fedier, A., Jacob, F., & Heinzelmann-Schwarz, V. (2018). ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer. PLOS ONE. https://doi.org/10.1371/journal.pone.0195213

Source records